Reference Values
9
3
3
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
Standardization of Spatial Neglect Assessment Tests
Trans & Non-binary Reference Intervals While on Hormone Therapy Study
Iron Status of Non-anemic Pregnant Women in First Trimester
Cardiac Normal Values Assessed by Magnetic Resonance Imaging
Remote Patient Monitoring and Detection of Possible Diseases With Artificial Intelligence Telemedicine System
Echocardiographic Assessment of the Right Ventricle in Healthy Subjects During Stress Test in the Mexican Population
Gestational Age Specific Thyroid Function Reference Range
Reference Values for Pulse Induced Continuous Cardiac Output (PiCCO) Variables in Children
Generation of Standard Laboratory Values for Pneumococci Antibodies